Research prototype, not medical advice.

Findings

What the data in the repository shows so far: published mouse lifespan results, which parts of the body our measure of biological age can already see, and the reproducible runs.

Mouse lifespan results (ITP)

The Interventions Testing Program feeds drugs to genetically mixed mice at three sites. Each dot is one group of treated mice (one drug, dose, start year and sex): how much longer, in percent, the middle mouse lived than in the untreated group. Green: the paper reports a lifespan gain. Grey: no clear effect. A hollow dot means some numbers in that file are still to be checked. Only the central value is shown: the files do not yet give uncertainty ranges, so no error bars are drawn. Click a dot to open its file.

108 of 132 groups have a median change; 74 of those still have numbers to check. Source: literature/lifespan/itp/.

-10%-5%0%+5%+10%+15%+20%+25%+30%+35%+40%2017-1-3-butanediol-100000ppm-183d-f: +1.5%1,3-butanediolfemales, 2017 cohort, 100000 ppm+1.5%2017-1-3-butanediol-100000ppm-183d-m: +9.3%males, 2017 cohort, 100000 ppm+9.3%2015-17-dmag-30ppm-183d-f: -4.3% (to check)17-DMAGfemales, 2015 cohort, 30 ppm-4.3% (to check)2015-17-dmag-30ppm-183d-m: +9.3% (to check)males, 2015 cohort, 30 ppm+9.3% (to check)2009-17-alpha-estradiol-4.8ppm-304d-f: -0.3% (to check)17-alpha-estradiolfemales, 2009 cohort, 4.8 ppm-0.3% (to check)2009-17-alpha-estradiol-4.8ppm-304d-m: +11.5% (to check)males, 2009 cohort, 4.8 ppm+11.5% (to check)2011-17-alpha-estradiol-14.4ppm-304d-f: +1.0% (to check)females, 2011 cohort, 14.4 ppm+1.0% (to check)2011-17-alpha-estradiol-14.4ppm-304d-m: +18.6% (to check)males, 2011 cohort, 14.4 ppm+18.6% (to check)2016-17-alpha-estradiol-14.4ppm-487d-m: +18.6%males, 2016 cohort, 14.4 ppm+18.6%2016-17-alpha-estradiol-14.4ppm-609d-m: +10.7%males, 2016 cohort, 14.4 ppm+10.7%2012-hbx-1ppm-457d-f: -2.4% (to check)2-(2-hydroxyphenyl)benzothiazolefemales, 2012 cohort, 1 ppm-2.4% (to check)2012-hbx-1ppm-457d-m: +0.7% (to check)males, 2012 cohort, 1 ppm+0.7% (to check)2016-mif098-240ppm-244d-f: -1.3%MIF098females, 2016 cohort, 240 ppm-1.3%2016-mif098-240ppm-244d-m: +4.3%males, 2016 cohort, 240 ppm+4.3%2015-mitoq-100ppm-213d-f: -1.7% (to check)MitoQfemales, 2015 cohort, 100 ppm-1.7% (to check)2015-mitoq-100ppm-213d-m: +1.6% (to check)males, 2015 cohort, 100 ppm+1.6% (to check)2014-tm5441-60ppm-335d-f: -0.3% (to check)TM5441females, 2014 cohort, 60 ppm-0.3% (to check)2014-tm5441-60ppm-335d-m: -3.6% (to check)males, 2014 cohort, 60 ppm-3.6% (to check)2009-acarbose-1000ppm-122d-f: +4.8% (to check)acarbosefemales, 2009 cohort, 1000 ppm+4.8% (to check)2009-acarbose-1000ppm-122d-m: +21.9% (to check)males, 2009 cohort, 1000 ppm+21.9% (to check)2012-acarbose-1000ppm-487d-f: +2.4% (to check)females, 2012 cohort, 1000 ppm+2.4% (to check)2012-acarbose-1000ppm-487d-m: +6.3% (to check)males, 2012 cohort, 1000 ppm+6.3% (to check)2013-acarbose-1000ppm-244d-f: +4.9%females, 2013 cohort, 1000 ppm+4.9%2013-acarbose-2500ppm-244d-f: +3.7%females, 2013 cohort, 2500 ppm+3.7%2013-acarbose-400ppm-244d-f: -0.2%females, 2013 cohort, 400 ppm-0.2%2013-acarbose-1000ppm-244d-m: +17.5%males, 2013 cohort, 1000 ppm+17.5%2013-acarbose-2500ppm-244d-m: +16.1%males, 2013 cohort, 2500 ppm+16.1%2013-acarbose-400ppm-244d-m: +10.6%males, 2013 cohort, 400 ppm+10.6%2004-aspirin-21ppm-122d-m: +8.0% (to check)aspirinmales, 2004 cohort, 21 ppm+8.0% (to check)2014-aspirin-200ppm-335d-f: +1.0% (to check)females, 2014 cohort, 200 ppm+1.0% (to check)2014-aspirin-60ppm-335d-f: +1.2% (to check)females, 2014 cohort, 60 ppm+1.2% (to check)2014-aspirin-200ppm-335d-m: +0.6% (to check)males, 2014 cohort, 200 ppm+0.6% (to check)2014-aspirin-60ppm-335d-m: -1.4% (to check)males, 2014 cohort, 60 ppm-1.4% (to check)2015-beta-gpa-3300ppm-183d-f: -1.3% (to check)beta-guanidinopropionic acidfemales, 2015 cohort, 3300 ppm-1.3% (to check)2015-beta-gpa-3300ppm-183d-m: -1.0% (to check)males, 2015 cohort, 3300 ppm-1.0% (to check)2016-canagliflozin-180ppm-213d-f: +1.4% (to check)canagliflozinfemales, 2016 cohort, 180 ppm+1.4% (to check)2016-canagliflozin-180ppm-213d-m: +14.0% (to check)males, 2016 cohort, 180 ppm+14.0% (to check)2016-candesartan-cilexetil-30ppm-244d-f: +0.7%candesartan cilexetilfemales, 2016 cohort, 30 ppm+0.7%2016-candesartan-cilexetil-30ppm-244d-m: +4.2%males, 2016 cohort, 30 ppm+4.2%2017-captopril-180ppm-152d-f: +5.4%captoprilfemales, 2017 cohort, 180 ppm+5.4%2017-captopril-180ppm-152d-m: +14.3%males, 2017 cohort, 180 ppm+14.3%2007-curcumin-2000ppm-122d-f: +4.5% (to check)curcuminfemales, 2007 cohort, 2000 ppm+4.5% (to check)2007-curcumin-2000ppm-122d-m: +2.8% (to check)males, 2007 cohort, 2000 ppm+2.8% (to check)2010-fish-oil-15000ppm-274d-f: -5.3% (to check)fish oilfemales, 2010 cohort, 15000 ppm-5.3% (to check)2010-fish-oil-50000ppm-274d-f: +2.1% (to check)females, 2010 cohort, 50000 ppm+2.1% (to check)2010-fish-oil-15000ppm-274d-m: +6.4% (to check)males, 2010 cohort, 15000 ppm+6.4% (to check)2010-fish-oil-50000ppm-274d-m: -4.0% (to check)males, 2010 cohort, 50000 ppm-4.0% (to check)2016-geranylgeranylacetone-600ppm-274d-f: +2.3%geranylgeranylacetonefemales, 2016 cohort, 600 ppm+2.3%2016-geranylgeranylacetone-600ppm-274d-m: +4.8%males, 2016 cohort, 600 ppm+4.8%2014-glycine-80000ppm-274d-f: +3.6%glycinefemales, 2014 cohort, 80000 ppm+3.6%2014-glycine-80000ppm-274d-m: +6.3%males, 2014 cohort, 80000 ppm+6.3%2007-green-tea-extract-2000ppm-122d-f: +6.6% (to check)green tea extractfemales, 2007 cohort, 2000 ppm+6.6% (to check)2007-green-tea-extract-2000ppm-122d-m: +4.6% (to check)males, 2007 cohort, 2000 ppm+4.6% (to check)2012-int-767-180ppm-304d-f: -1.0% (to check)int-767females, 2012 cohort, 180 ppm-1.0% (to check)2012-int-767-180ppm-304d-m: -3.1% (to check)males, 2012 cohort, 180 ppm-3.1% (to check)2014-inulin-600ppm-335d-f: +1.4% (to check)inulinfemales, 2014 cohort, 600 ppm+1.4% (to check)2014-inulin-600ppm-335d-m: -2.0% (to check)males, 2014 cohort, 600 ppm-2.0% (to check)2017-leucine-40000ppm-152d-f: -1.7%leucinefemales, 2017 cohort, 40000 ppm-1.7%2017-leucine-40000ppm-152d-m: +0.3%males, 2017 cohort, 40000 ppm+0.3%2007-mct-oil-60000ppm-122d-f: +1.8% (to check)medium-chain triglyceride oilfemales, 2007 cohort, 60000 ppm+1.8% (to check)2007-mct-oil-60000ppm-122d-m: -1.1% (to check)males, 2007 cohort, 60000 ppm-1.1% (to check)2011-metformin-1000ppm-274d-f: -0.2% (to check)metforminfemales, 2011 cohort, 1000 ppm-0.2% (to check)2011-metformin-1000ppm-274d-m: +7.1% (to check)males, 2011 cohort, 1000 ppm+7.1% (to check)2011-metformin-rapamycin-1000-14ppm-274d-f: +23.3% (to check)metformin + rapamycinfemales, 2011 cohort, 1000+14 ppm+23.3% (to check)2011-metformin-rapamycin-1000-14ppm-274d-m: +22.9% (to check)males, 2011 cohort, 1000+14 ppm+22.9% (to check)2009-methylene-blue-28ppm-122d-f: +0.7% (to check)methylene bluefemales, 2009 cohort, 28 ppm+0.7% (to check)2009-methylene-blue-28ppm-122d-m: -2.1% (to check)males, 2009 cohort, 28 ppm-2.1% (to check)2015-minocycline-300ppm-183d-f: -3.0% (to check)minocyclinefemales, 2015 cohort, 300 ppm-3.0% (to check)2015-minocycline-300ppm-183d-m: +4.5% (to check)males, 2015 cohort, 300 ppm+4.5% (to check)2004-ndga-2500ppm-274d-m: +12.1% (to check)ndgamales, 2004 cohort, 2500 ppm+12.1% (to check)2010-ndga-5000ppm-183d-f: -2.9% (to check)females, 2010 cohort, 5000 ppm-2.9% (to check)2010-ndga-2500ppm-183d-m: +9.1% (to check)males, 2010 cohort, 2500 ppm+9.1% (to check)2010-ndga-5000ppm-183d-m: +7.6% (to check)males, 2010 cohort, 5000 ppm+7.6% (to check)2010-ndga-800ppm-183d-m: +6.5% (to check)males, 2010 cohort, 800 ppm+6.5% (to check)2016-nicotinamide-riboside-1000ppm-244d-f: +0.1%nicotinamide ribosidefemales, 2016 cohort, 1000 ppm+0.1%2016-nicotinamide-riboside-1000ppm-244d-m: -3.0%males, 2016 cohort, 1000 ppm-3.0%2007-oxaloacetic-acid-2200ppm-122d-f: +2.7% (to check)oxaloacetic acidfemales, 2007 cohort, 2200 ppm+2.7% (to check)2007-oxaloacetic-acid-2200ppm-122d-m: +4.2% (to check)males, 2007 cohort, 2200 ppm+4.2% (to check)2017-pb125-4.7+9+0.47ppm-152d-f: +0.8%pb125females, 2017 cohort, 4.7+9+0.47 ppm+0.8%2017-pb125-4.7+9+0.47ppm-152d-m: -2.6%males, 2017 cohort, 4.7+9+0.47 ppm-2.6%2011-protandim-600ppm-304d-f: +2.5% (to check)protandimfemales, 2011 cohort, 600 ppm+2.5% (to check)2011-protandim-600ppm-304d-m: +6.9% (to check)males, 2011 cohort, 600 ppm+6.9% (to check)2009-rapamycin-14ppm-274d-f: +21.2% (to check)rapamycinfemales, 2009 cohort, 14 ppm+21.2% (to check)2009-rapamycin-4.7ppm-274d-f: +16.4% (to check)females, 2009 cohort, 4.7 ppm+16.4% (to check)2009-rapamycin-42ppm-274d-f: +26.3% (to check)females, 2009 cohort, 42 ppm+26.3% (to check)2009-rapamycin-14ppm-274d-m: +12.6% (to check)males, 2009 cohort, 14 ppm+12.6% (to check)2009-rapamycin-4.7ppm-274d-m: +3.3% (to check)males, 2009 cohort, 4.7 ppm+3.3% (to check)2009-rapamycin-42ppm-274d-m: +22.9% (to check)males, 2009 cohort, 42 ppm+22.9% (to check)2015-rapamycin-42ppm-604d-cycles-f: +8.0% (to check)females, 2015 cohort, 42 ppm+8.0% (to check)2015-rapamycin-42ppm-604d-f: +14.9% (to check)females, 2015 cohort, 42 ppm+14.9% (to check)2015-rapamycin-42ppm-604d-stop23mo-f: +3.9% (to check)females, 2015 cohort, 42 ppm+3.9% (to check)2015-rapamycin-42ppm-604d-cycles-m: +8.9% (to check)males, 2015 cohort, 42 ppm+8.9% (to check)2015-rapamycin-42ppm-604d-m: +10.9% (to check)males, 2015 cohort, 42 ppm+10.9% (to check)2015-rapamycin-42ppm-604d-stop23mo-m: +10.6% (to check)males, 2015 cohort, 42 ppm+10.6% (to check)2017-rapamycin-acarbose-14.7+1000ppm-274d-f: +27.5%rapamycin + acarbosefemales, 2017 cohort, 14.7+1000 ppm+27.5%2017-rapamycin-acarbose-14.7+1000ppm-487d-f: +12.4%females, 2017 cohort, 14.7+1000 ppm+12.4%2017-rapamycin-acarbose-14.7+1000ppm-274d-m: +36.6%males, 2017 cohort, 14.7+1000 ppm+36.6%2017-rapamycin-acarbose-14.7+1000ppm-487d-m: +13.5%males, 2017 cohort, 14.7+1000 ppm+13.5%2007-resveratrol-300ppm-122d-f: +4.7% (to check)resveratrolfemales, 2007 cohort, 300 ppm+4.7% (to check)2007-resveratrol-300ppm-122d-m: +3.4% (to check)males, 2007 cohort, 300 ppm+3.4% (to check)2017-sulindac-5ppm-152d-f: -1.7%sulindacfemales, 2017 cohort, 5 ppm-1.7%2017-sulindac-5ppm-152d-m: -2.8%males, 2017 cohort, 5 ppm-2.8%2017-syringaresinol-300ppm-152d-f: -1.7%syringaresinolfemales, 2017 cohort, 300 ppm-1.7%2017-syringaresinol-300ppm-152d-m: +6.3%males, 2017 cohort, 300 ppm+6.3%2011-udca-5000ppm-152d-f: -1.0% (to check)ursodeoxycholic acidfemales, 2011 cohort, 5000 ppm-1.0% (to check)2011-udca-5000ppm-152d-m: +6.7% (to check)males, 2011 cohort, 5000 ppm+6.7% (to check)2013-ursolic-acid-2000ppm-304d-f: -0.4% (to check)ursolic acidfemales, 2013 cohort, 2000 ppm-0.4% (to check)2013-ursolic-acid-2000ppm-304d-m: +6.4% (to check)males, 2013 cohort, 2000 ppm+6.4% (to check)
24 group(s) with no median change in the file yet

Coverage of the biological-age measure

Biological age is measured on many axes: one per organ system and one per hallmark of ageing. An axis with no public data to read it from is a blind spot; it stays on the list until one is found. Source: research/metric/v0/axes.md (draft).

35 axes: 12 with a public readout 13 with molecular data only 10 blind spots

Organ systems

Hallmarks of ageing

Simulation challenge (R-Sim v0)

Our simulation models each organ as a balance: damage is made at some rate and repaired at some rate. Measuring old mice only shows the balance, not the two rates, so we cannot tell "makes a lot of damage, repairs a lot" from "makes little, repairs little". A challenge is a deliberate, controlled injury (for example a drug that briefly harms the kidney), followed by measurements over the next 26 weeks: how fast the organ recovers tells the two rates apart. These results are from the simulation only; no mouse has been used.

Which challenges tell damage made apart from damage repaired

Each cell is one simulated experiment with 100 mice per measurement time: one organ, injured at 6 or 18 months of age, with a small, medium or large injury (0.15, 0.3 or 0.6 of the damage level the organ can stand). The number, from 0 to 1, says how well that experiment separates damage made from damage repaired. Dark cells, 0.8 and above, count as split: the two rates can be told apart. The three panels assume three values of kappa, how quickly repair hits its limit as damage builds up: 0.5 is our current guess, 2 and 8 mean repair stays far from its limit. Splitting happens only for injuries at 6 months with the medium or large dose, and nowhere when kappa is 8. Click a cell to open the file.

MuscleBrainHeartLungKidneyLiver and metabolismImmune systemBloodSkin and hairGutFatRepair limit kappa 0.5 (current guess)injured at 6 months0.150.30.6injured at 18 months0.150.30.6Muscle, injured at 6 months, injury 0.15: 0.220.22Muscle, injured at 6 months, injury 0.3: 0.920.92Muscle, injured at 6 months, injury 0.6: 0.980.98Muscle, injured at 18 months, injury 0.15: 0.190.19Muscle, injured at 18 months, injury 0.3: 0.160.16Muscle, injured at 18 months, injury 0.6: 0.140.14Brain, injured at 6 months, injury 0.15: 0.190.19Brain, injured at 6 months, injury 0.3: 0.200.20Brain, injured at 6 months, injury 0.6: 0.980.98Brain, injured at 18 months, injury 0.15: 0.200.20Brain, injured at 18 months, injury 0.3: 0.160.16Brain, injured at 18 months, injury 0.6: 0.060.06Heart, injured at 6 months, injury 0.15: 0.200.20Heart, injured at 6 months, injury 0.3: 0.200.20Heart, injured at 6 months, injury 0.6: 0.970.97Heart, injured at 18 months, injury 0.15: 0.190.19Heart, injured at 18 months, injury 0.3: 0.140.14Heart, injured at 18 months, injury 0.6: 0.060.06Lung, injured at 6 months, injury 0.15: 0.190.19Lung, injured at 6 months, injury 0.3: 0.950.95Lung, injured at 6 months, injury 0.6: 0.970.97Lung, injured at 18 months, injury 0.15: 0.200.20Lung, injured at 18 months, injury 0.3: 0.160.16Lung, injured at 18 months, injury 0.6: 0.060.06Kidney, injured at 6 months, injury 0.15: 0.220.22Kidney, injured at 6 months, injury 0.3: 0.200.20Kidney, injured at 6 months, injury 0.6: 0.960.96Kidney, injured at 18 months, injury 0.15: 0.210.21Kidney, injured at 18 months, injury 0.3: 0.160.16Kidney, injured at 18 months, injury 0.6: 0.060.06Liver and metabolism, injured at 6 months, injury 0.15: 0.190.19Liver and metabolism, injured at 6 months, injury 0.3: 0.960.96Liver and metabolism, injured at 6 months, injury 0.6: 0.960.96Liver and metabolism, injured at 18 months, injury 0.15: 0.210.21Liver and metabolism, injured at 18 months, injury 0.3: 0.150.15Liver and metabolism, injured at 18 months, injury 0.6: 0.080.08Immune system, injured at 6 months, injury 0.15: 0.200.20Immune system, injured at 6 months, injury 0.3: 0.210.21Immune system, injured at 6 months, injury 0.6: 0.960.96Immune system, injured at 18 months, injury 0.15: 0.210.21Immune system, injured at 18 months, injury 0.3: 0.160.16Immune system, injured at 18 months, injury 0.6: 0.070.07Blood, injured at 6 months, injury 0.15: 0.210.21Blood, injured at 6 months, injury 0.3: 0.930.93Blood, injured at 6 months, injury 0.6: 0.970.97Blood, injured at 18 months, injury 0.15: 0.220.22Blood, injured at 18 months, injury 0.3: 0.150.15Blood, injured at 18 months, injury 0.6: 0.060.06Skin and hair, injured at 6 months, injury 0.15: 0.230.23Skin and hair, injured at 6 months, injury 0.3: 0.880.88Skin and hair, injured at 6 months, injury 0.6: 0.960.96Skin and hair, injured at 18 months, injury 0.15: 0.190.19Skin and hair, injured at 18 months, injury 0.3: 0.160.16Skin and hair, injured at 18 months, injury 0.6: 0.140.14Gut, injured at 6 months, injury 0.15: 0.240.24Gut, injured at 6 months, injury 0.3: 0.900.90Gut, injured at 6 months, injury 0.6: 0.970.97Gut, injured at 18 months, injury 0.15: 0.190.19Gut, injured at 18 months, injury 0.3: 0.160.16Gut, injured at 18 months, injury 0.6: 0.130.13Fat, injured at 6 months, injury 0.15: 0.240.24Fat, injured at 6 months, injury 0.3: 0.890.89Fat, injured at 6 months, injury 0.6: 0.960.96Fat, injured at 18 months, injury 0.15: 0.180.18Fat, injured at 18 months, injury 0.3: 0.150.15Fat, injured at 18 months, injury 0.6: 0.130.13Repair limit kappa 2injured at 6 months0.150.30.6injured at 18 months0.150.30.6Muscle, injured at 6 months, injury 0.15: 0.200.20Muscle, injured at 6 months, injury 0.3: 0.190.19Muscle, injured at 6 months, injury 0.6: 0.880.88Muscle, injured at 18 months, injury 0.15: 0.240.24Muscle, injured at 18 months, injury 0.3: 0.220.22Muscle, injured at 18 months, injury 0.6: 0.200.20Brain, injured at 6 months, injury 0.15: 0.230.23Brain, injured at 6 months, injury 0.3: 0.220.22Brain, injured at 6 months, injury 0.6: 0.980.98Brain, injured at 18 months, injury 0.15: 0.250.25Brain, injured at 18 months, injury 0.3: 0.190.19Brain, injured at 18 months, injury 0.6: 0.170.17Heart, injured at 6 months, injury 0.15: 0.220.22Heart, injured at 6 months, injury 0.3: 0.190.19Heart, injured at 6 months, injury 0.6: 0.150.15Heart, injured at 18 months, injury 0.15: 0.220.22Heart, injured at 18 months, injury 0.3: 0.200.20Heart, injured at 18 months, injury 0.6: 0.170.17Lung, injured at 6 months, injury 0.15: 0.210.21Lung, injured at 6 months, injury 0.3: 0.200.20Lung, injured at 6 months, injury 0.6: 0.890.89Lung, injured at 18 months, injury 0.15: 0.240.24Lung, injured at 18 months, injury 0.3: 0.210.21Lung, injured at 18 months, injury 0.6: 0.140.14Kidney, injured at 6 months, injury 0.15: 0.210.21Kidney, injured at 6 months, injury 0.3: 0.190.19Kidney, injured at 6 months, injury 0.6: 0.790.79Kidney, injured at 18 months, injury 0.15: 0.240.24Kidney, injured at 18 months, injury 0.3: 0.210.21Kidney, injured at 18 months, injury 0.6: 0.150.15Liver and metabolism, injured at 6 months, injury 0.15: 0.200.20Liver and metabolism, injured at 6 months, injury 0.3: 0.180.18Liver and metabolism, injured at 6 months, injury 0.6: 0.920.92Liver and metabolism, injured at 18 months, injury 0.15: 0.220.22Liver and metabolism, injured at 18 months, injury 0.3: 0.190.19Liver and metabolism, injured at 18 months, injury 0.6: 0.170.17Immune system, injured at 6 months, injury 0.15: 0.230.23Immune system, injured at 6 months, injury 0.3: 0.240.24Immune system, injured at 6 months, injury 0.6: 0.930.93Immune system, injured at 18 months, injury 0.15: 0.250.25Immune system, injured at 18 months, injury 0.3: 0.200.20Immune system, injured at 18 months, injury 0.6: 0.150.15Blood, injured at 6 months, injury 0.15: 0.220.22Blood, injured at 6 months, injury 0.3: 0.180.18Blood, injured at 6 months, injury 0.6: 0.120.12Blood, injured at 18 months, injury 0.15: 0.220.22Blood, injured at 18 months, injury 0.3: 0.190.19Blood, injured at 18 months, injury 0.6: 0.130.13Skin and hair, injured at 6 months, injury 0.15: 0.200.20Skin and hair, injured at 6 months, injury 0.3: 0.190.19Skin and hair, injured at 6 months, injury 0.6: 0.170.17Skin and hair, injured at 18 months, injury 0.15: 0.230.23Skin and hair, injured at 18 months, injury 0.3: 0.220.22Skin and hair, injured at 18 months, injury 0.6: 0.200.20Gut, injured at 6 months, injury 0.15: 0.200.20Gut, injured at 6 months, injury 0.3: 0.190.19Gut, injured at 6 months, injury 0.6: 0.180.18Gut, injured at 18 months, injury 0.15: 0.230.23Gut, injured at 18 months, injury 0.3: 0.220.22Gut, injured at 18 months, injury 0.6: 0.200.20Fat, injured at 6 months, injury 0.15: 0.210.21Fat, injured at 6 months, injury 0.3: 0.200.20Fat, injured at 6 months, injury 0.6: 0.190.19Fat, injured at 18 months, injury 0.15: 0.230.23Fat, injured at 18 months, injury 0.3: 0.210.21Fat, injured at 18 months, injury 0.6: 0.190.19Repair limit kappa 8injured at 6 months0.150.30.6injured at 18 months0.150.30.6Muscle, injured at 6 months, injury 0.15: 0.190.19Muscle, injured at 6 months, injury 0.3: 0.190.19Muscle, injured at 6 months, injury 0.6: 0.180.18Muscle, injured at 18 months, injury 0.15: 0.230.23Muscle, injured at 18 months, injury 0.3: 0.230.23Muscle, injured at 18 months, injury 0.6: 0.220.22Brain, injured at 6 months, injury 0.15: 0.050.05Brain, injured at 6 months, injury 0.3: 0.040.04Brain, injured at 6 months, injury 0.6: 0.000.00Brain, injured at 18 months, injury 0.15: 0.040.04Brain, injured at 18 months, injury 0.3: 0.020.02Brain, injured at 18 months, injury 0.6: 0.010.01Heart, injured at 6 months, injury 0.15: 0.120.12Heart, injured at 6 months, injury 0.3: 0.130.13Heart, injured at 6 months, injury 0.6: 0.150.15Heart, injured at 18 months, injury 0.15: 0.180.18Heart, injured at 18 months, injury 0.3: 0.170.17Heart, injured at 18 months, injury 0.6: 0.170.17Lung, injured at 6 months, injury 0.15: 0.000.00Lung, injured at 6 months, injury 0.3: 0.000.00Lung, injured at 6 months, injury 0.6: 0.000.00Lung, injured at 18 months, injury 0.15: 0.020.02Lung, injured at 18 months, injury 0.3: 0.010.01Lung, injured at 18 months, injury 0.6: 0.000.00Kidney, injured at 6 months, injury 0.15: 0.000.00Kidney, injured at 6 months, injury 0.3: 0.000.00Kidney, injured at 6 months, injury 0.6: 0.010.01Kidney, injured at 18 months, injury 0.15: 0.070.07Kidney, injured at 18 months, injury 0.3: 0.030.03Kidney, injured at 18 months, injury 0.6: 0.000.00Liver and metabolism, injured at 6 months, injury 0.15: 0.400.40Liver and metabolism, injured at 6 months, injury 0.3: 0.410.41Liver and metabolism, injured at 6 months, injury 0.6: 0.410.41Liver and metabolism, injured at 18 months, injury 0.15: 0.440.44Liver and metabolism, injured at 18 months, injury 0.3: 0.430.43Liver and metabolism, injured at 18 months, injury 0.6: 0.390.39Immune system, injured at 6 months, injury 0.15: 0.030.03Immune system, injured at 6 months, injury 0.3: 0.030.03Immune system, injured at 6 months, injury 0.6: 0.130.13Immune system, injured at 18 months, injury 0.15: 0.040.04Immune system, injured at 18 months, injury 0.3: 0.230.23Immune system, injured at 18 months, injury 0.6: 0.150.15Blood, injured at 6 months, injury 0.15: 0.110.11Blood, injured at 6 months, injury 0.3: 0.100.10Blood, injured at 6 months, injury 0.6: 0.390.39Blood, injured at 18 months, injury 0.15: 0.410.41Blood, injured at 18 months, injury 0.3: 0.410.41Blood, injured at 18 months, injury 0.6: 0.360.36Skin and hair, injured at 6 months, injury 0.15: 0.360.36Skin and hair, injured at 6 months, injury 0.3: 0.360.36Skin and hair, injured at 6 months, injury 0.6: 0.370.37Skin and hair, injured at 18 months, injury 0.15: 0.230.23Skin and hair, injured at 18 months, injury 0.3: 0.230.23Skin and hair, injured at 18 months, injury 0.6: 0.220.22Gut, injured at 6 months, injury 0.15: 0.210.21Gut, injured at 6 months, injury 0.3: 0.210.21Gut, injured at 6 months, injury 0.6: 0.210.21Gut, injured at 18 months, injury 0.15: 0.240.24Gut, injured at 18 months, injury 0.3: 0.230.23Gut, injured at 18 months, injury 0.6: 0.230.23Fat, injured at 6 months, injury 0.15: 0.000.00Fat, injured at 6 months, injury 0.3: 0.000.00Fat, injured at 6 months, injury 0.6: 0.000.00Fat, injured at 18 months, injury 0.15: 0.210.21Fat, injured at 18 months, injury 0.3: 0.200.20Fat, injured at 18 months, injury 0.6: 0.200.20

below 0.2 0.2 to 0.5 0.5 to 0.8 0.8 and above: split

Source: result-20000.json (20 000 simulated mice per setting, GitHub Actions run 39594585409).

How many mice an experiment would need

The same results, read as a budget: for a given number of mice per sex, the most organs that any challenge design of that size or smaller can split. A design picks the age(s) at injury, the dose(s), and the number of mice per measurement time. Solid lines count all organs; dashed lines count only organs whose measurement can be repeated on the same mice (heart scan, kidney filtration, blood count, gut), the cheapest kind of experiment. At our current guess for kappa, about 200 mice per sex split the four repeatable organs; 300 per sex (two doses) still works if kappa is 2. If kappa is 8, no design up to 700 mice splits anything: kappa must be pinned down first. Click the chart to open the file.

0123456789101120304050607090120150200210300400500700mice per sex (smallest design of at most this size)kappa 0.5 (current guess)kappa 2kappa 8all organsorgans with a repeatable readoutkappa 0.5: all organskappa 0.5: repeatable readoutkappa 2: all organskappa 2: repeatable readoutkappa 8: all organskappa 8: repeatable readout

Source: cost-curve.json. Method and full table: identifiability.md (section 11). Public data that could stand in for mice: public-data.md.

Reproducible runs

Each run is re-run on every change and must give the same output files, byte for byte. Source: research/runs/.

RunWhat it isSeedOutput files
sim-v0-challenge-2026-10-21 R-Sim v0 challenge cost grid, baseline shard seed 11 kappa 0 A1_muscle at n_sim 20000 (one of 462 shards of Actions run 39594585409) 11 cb_11_kprior_A1_muscle.json
sim-v0-joint-2026-10-20 R-Sim v0 joint Fisher, base shard seed 11 at n_sim 20000 (one of 436 shards of Actions run 39478866080) 11 11_base_base.json
toy-gompertz-v0 Toy seeded Gompertz lifespan run; platform fixture for the re-run job, not science 42 output.csv